MSc in Cardiometabolic Medicine - NKUA

Just a few days before the 4th Congress “Σακχαρώδης Διαβήτης στον Καρδιοπαθή”, 4ο Συνέδριο Σακχαρώδης Διαβήτης στον Καρδιοπαθή, https://projector-web.gr/Mindview/gr/4o-sinedrio-sakcharodi-diaviti-ston-kardiopathi
📅 October 31 – November 1, 2025
He are happy for this publication in Endocrine (Springer Nature):
“Cardiometabolic outpatient clinics: evidence from collaborative academic tertiary centers”
(E. Korakas, V. Tsigkou, L. Pliouta, S. Lampsas, E. Oikonomou, A. Tsatsaragkou, M. Xenou, E. Anastasopoulou, I. Ikonomidis, V. Lambadiari, G. Siasos)
👉 DOI: 10.1007/s12020-025-04450-1
https://link.springer.com/article/10.1007/s12020-025-04450-1
This work, provides real-world evidence that multidisciplinary cardiometabolic clinics — where diabetologists and cardiologists work together — can significantly improve outcomes in patients with type 2 diabetes mellitus (T2DM).
🔹 Major improvements were seen in HbA1c, LDL cholesterol, and BMI
🔹 78% of very high-risk patients reached LDL

4o Συνέδριο - Προσεγγίζοντας τον Σαγχαρώδη Διαβήτη στον Καρδιοπαθή | Mindview | Projector-web.gr Events Production & Support

31 Οκτωβρίου έως την 1 Νοεμβρίου 2025 στο Κεντρικό Κτίριο (Προπύλαια) του Εθνικού και Καποδιστριακού Πανεπιστημίου Αθηνών
https://projector-web.gr/Mindview/gr/4o-sinedrio-sakcharodi-diaviti-ston-kardiopathi

📢 Αύριο Πέμπτη 2/10/2025 στις 20:00 μπορείτε να παρακολουθήσετε ένα πολύ ενδιαφέρον Webinar της Ελληνικής Καρδιολογικής Εταιρείας

🔹 Ομάδες Εργασίας:
Καρδιάς & Διαβήτη
Αορτής & Περιφερικών Αγγείων

🖥️ Συνδεθείτε
👉https://us02web.zoom.us/j/89843459846?pwd=xuzas5N9n8IkQP7TyQLKMeJp72pOpa.1

🔑 Passcode: 900430

📅 Πέμπτη 02 Οκτωβρίου 2025 | 20:00
📍 Θέμα: Ο.Ε. Καρδιάς & Διαβήτη & Ο.Ε. Αορτής & Περιφερικών Αγγείων

Νεα Επιστημονική Δημοσιευση από τους Φοιτητές του ΠΜΣ "Καρδιομεταβολική Ιατρική"
"The Role of NLRP3 Inflammasome in Type 2 Diabetes Mellitus and Its Macrovascular Complications"

Η εργασία αυτή υπογραμμίζει τη δυναμική επιστημονική δραστηριότητα των φοιτητών του ΠΜΣ «Καρδιομεταβολική Ιατρική», επιβεβαιώνοντας το υψηλό επίπεδο σπουδών του προγράμματος.

Διαβάστε το άρθρο εδώ:
Website: https://www.mdpi.com/2077-0383/14/13/4606
PDF Version: https://www.mdpi.com/2077-0383/14/13/4606/pdf

📬 Ενδιαφέρεστε να συμμετάσχετε στο μεταπτυχιακό μας πρόγραμμα;
Οι αιτήσεις συνεχίζονται!

📧 [email protected]
📞 210-7763734
Περισσότερες πληροφορίες: https://hub.uoa.gr/prokiryxi-pms-kardiometavoliki-iatriki/?fbclid=IwY2xjawLRoJVleHRuA2FlbQIxMQBicmlkETA3dmNERGxXcnE5akxEVG5MAR6YkI9IWeCh7kpcH62bByJNsGL5yBYbo2ngM8HKOqv3eiK1LxbR_9shO1kY9g_aem_5IFvNTTHeGXff2iAIWY8xg

Arterial Stiffness as a Complication of Metabolic Dysfunction-Associated Steatotic Liver Disease: A Systematic Review and Meta-Analysis",
This systematic Review and Meta-analysis has been published in the Expert Review of Gastroenterology & Hepatology! 🎉✨
🔬 This research is part of the MSc Thesis in Cardiometabolic Medicine (Learn more: https://cardiometabolic.med.uoa.gr/), reinforcing our commitment to advancing knowledge in cardiometabolic health.
💡 Key Findings of the Study:
✅ Confirms a strong link between MASLD and increased arterial stiffness, a crucial cardiovascular risk factor.
✅ Meta-analysis of 27 studies reveals that MASLD patients have significantly higher pulse wave velocity (PWV) and augmentation index (AIx) than healthy individuals.
✅ This association remains independent of common cardiometabolic risk factors such as BMI, blood pressure, and glucose levels.
📌 Read the full article here: https://doi.org/10.1080/17474124.2025.2471871
🔗 Interested in Cardiometabolic Medicine? Learn more about the MSc program here: https://cardiometabolic.med.uoa.gr/

We are delighted to share that the article "Unraveling Metabolic Dysfunction-Associated Steatotic Liver Disease Through the Use of Omics Technologies" has been published in the International Journal of Molecular Sciences! 🎉✨
This publication based on the MSc thesis work for the MSc in Cardiometabolic Medicine (Learn more "https://cardiometabolic.med.uoa.gr/"), contributing valuable insights into Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) and how omics technologies can transform its diagnosis and treatment.
🔬 Key Highlights of the Study:
✅ Explores the role of genomics, transcriptomics, proteomics, and metabolomics in MASLD.
✅ Emphasizes the need for non-invasive tools for early disease detection and personalized medicine.
✅ Provides insights into the molecular pathways driving MASLD progression.
💐 Special congratulations to Dr. Maria Bougranou, the first author of this study, and to Prof. Eva Kassi, whose efforts and inspiration made this work possible!
📌 Read the full article here: [https://www.mdpi.com/3181038]
🎓🔬💙

Unraveling Metabolic Dysfunction-Associated Steatotic Liver Disease Through the Use of Omics Technologies Non-alcoholic fatty liver disease (NAFLD), now referred to as metabolic dysfunction-associated steatotic liver disease (MASLD), is the most prevalent liver disorder globally, linked to obesity, type 2 diabetes, and cardiovascular risk. Understanding its potential progression from simple steatosis to...

🎉 Proudly Announcing the Publication of a systematic review by one of our MSc students from the Cardiometabolic Medicine program (Learn more "https://cardiometabolic.med.uoa.gr/") 📖✨ You can read the full article here: (https://pubmed.ncbi.nlm.nih.gov/39936443/)

📊 Research Highlights:
🔬 Explores the role of microRNAs (miRNAs) in liver disease progression—from non-alcoholic fatty liver Disease (NAFLD or MAFLD) to hepatocellular carcinoma (HCC).
🧬 Reveals how specific miRNAs regulate lipid metabolism, insulin resistance, and fibrosis, contributing to disease progression.

👏 Congratulations to our MSc student 💙✨

14 Νοεμβρίου. Παγκόσμια Ημέρα Διαβήτη. Ενημερωτική Εκδήλωση της Ομάδας Εργασίας Καρδιάς και Διαβήτη της Ελληνικής Καρδιολογικής Εταιρείας στο Πνευματικό κέντρο του Δήμου Χαιδαρίου.